{"transactions":[{"id":932014,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-23T23:11:25.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":1687,"price":1.86,"value":3137.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024."}],"balance_after":304924,"source":{"system":"sec-edgar","filing":"0001628280-26-003347","document":"wk-form4_1769209883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026003347/wk-form4_1769209883.xml","form_type":"4"}},{"id":932013,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-23T23:11:25.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":2473,"price":1.8072,"value":4469.2056,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7650 to $1.8700. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":306611,"source":{"system":"sec-edgar","filing":"0001628280-26-003347","document":"wk-form4_1769209883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026003347/wk-form4_1769209883.xml","form_type":"4"}},{"id":934035,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-21T23:32:05.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":148700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":148700,"derivative":{"exercise_price":1.89,"expiration_date":"2036-01-16","underlying":"Common Stock","underlying_shares":148700},"source":{"system":"sec-edgar","filing":"0001628280-26-002961","document":"wk-form4_1769038322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026002961/wk-form4_1769038322.xml","form_type":"4"}},{"id":934034,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-21T23:32:05.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":99133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":309084,"source":{"system":"sec-edgar","filing":"0001628280-26-002961","document":"wk-form4_1769038322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026002961/wk-form4_1769038322.xml","form_type":"4"}},{"id":940760,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-12T23:52:52.000Z","date":"2026-01-08","kind":"sale","planned":false,"acquired":false,"shares":6888,"price":1.8166,"value":12512.7408,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7200 to $1.9500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":209951,"source":{"system":"sec-edgar","filing":"0001628280-26-001898","document":"wk-form4_1768261959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026001898/wk-form4_1768261959.xml","form_type":"4"}},{"id":944016,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-08T02:31:50.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":1700,"price":1.9862,"value":3376.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9600 to $2.0100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":216839,"source":{"system":"sec-edgar","filing":"0001628280-26-001265","document":"wk-form4_1767839507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026001265/wk-form4_1767839507.xml","form_type":"4"}},{"id":944015,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-08T02:31:50.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":4105,"price":1.995,"value":8189.475,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0400. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":218539,"source":{"system":"sec-edgar","filing":"0001628280-26-001265","document":"wk-form4_1767839507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026001265/wk-form4_1767839507.xml","form_type":"4"}},{"id":944014,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-08T02:31:50.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":5100,"price":1.9662,"value":10027.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $1.9900. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":222644,"source":{"system":"sec-edgar","filing":"0001628280-26-001265","document":"wk-form4_1767839507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026001265/wk-form4_1767839507.xml","form_type":"4"}},{"id":944013,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-08T02:31:50.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":1.9606,"value":7842.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9100 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":227744,"source":{"system":"sec-edgar","filing":"0001628280-26-001265","document":"wk-form4_1767839507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000162828026001265/wk-form4_1767839507.xml","form_type":"4"}},{"id":1127172,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T21:00:12.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":60339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":60339,"derivative":{"exercise_price":1.65,"expiration_date":"2035-05-29","underlying":"Class A Common Stock","underlying_shares":60339},"source":{"system":"sec-edgar","filing":"0001415889-25-015202","document":"form4-06022025_050608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708527/000141588925015202/form4-06022025_050608.xml","form_type":"4"}},{"id":1208031,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":2,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":3,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":6,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":7,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42460,"kind":"organization","name":"HighCape Partners GP II, L.P.","position":9,"cik":"0001957359","reported_name":"HighCape Partners GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":10,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-13T20:28:27.000Z","date":"2025-02-03","kind":"purchase","planned":false,"acquired":true,"shares":420000,"price":2.5,"value":1050000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P; (vi) 95,197 shares of Common Stock held of record by HighCape Partners II, L.P.; and (vii) 4,562,431 shares of Common Stock held of record by HighCape Partners QP II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner (\"GP\") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P. and HighCape Partners QP II, L.P. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."}],"balance_after":9520232,"source":{"system":"sec-edgar","filing":"0001104659-25-023484","document":"tm259106-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1957359/000110465925023484/tm259106-1_4seq1.xml","form_type":"4"}},{"id":1296206,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-24T02:19:28.000Z","date":"2025-01-23","kind":"sale","planned":true,"acquired":false,"shares":28902,"price":1.7173,"value":49633.4046,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares sold by the Reporting Person in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.6705 to $1.7699. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":231744,"source":{"system":"sec-edgar","filing":"0001576885-25-000037","document":"wk-form4_1737685161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688525000037/wk-form4_1737685161.xml","form_type":"4"}},{"id":1296205,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-24T02:19:28.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":4364,"price":1.6009,"value":6986.3276,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.5800 to $1.6100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":260646,"source":{"system":"sec-edgar","filing":"0001576885-25-000037","document":"wk-form4_1737685161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688525000037/wk-form4_1737685161.xml","form_type":"4"}},{"id":1307549,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-08T00:53:29.000Z","date":"2025-01-06","kind":"grant","planned":true,"acquired":true,"shares":100300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":100300,"derivative":{"exercise_price":1.85,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":100300},"source":{"system":"sec-edgar","filing":"0001576885-25-000011","document":"wk-form4_1736297601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688525000011/wk-form4_1736297601.xml","form_type":"4"}},{"id":1307548,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-08T00:53:29.000Z","date":"2025-01-06","kind":"grant","planned":true,"acquired":true,"shares":66800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an RSU award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":265010,"source":{"system":"sec-edgar","filing":"0001576885-25-000011","document":"wk-form4_1736297601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688525000011/wk-form4_1736297601.xml","form_type":"4"}},{"id":1307547,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-08T00:53:29.000Z","date":"2025-01-03","kind":"sale","planned":true,"acquired":false,"shares":13235,"price":1.8411,"value":24366.9585,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7700 to $1.9000. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":198210,"source":{"system":"sec-edgar","filing":"0001576885-25-000011","document":"wk-form4_1736297601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688525000011/wk-form4_1736297601.xml","form_type":"4"}},{"id":1444443,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":2,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":3,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":6,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":7,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42461,"kind":"organization","name":"HighCape Partners QP II, L.P.","position":8,"cik":"0001770972","reported_name":"HighCape Partners QP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42459,"kind":"organization","name":"HighCape Partners GP II, LLC","position":9,"cik":"0001957360","reported_name":"HighCape Partners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42460,"kind":"organization","name":"HighCape Partners GP II, L.P.","position":10,"cik":"0001957359","reported_name":"HighCape Partners GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-08-01T20:54:16.000Z","date":"2024-07-30","kind":"other","planned":false,"acquired":false,"shares":2101577,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrant has expired.  The warrant provided for expiration upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope (which has elapsed) or (b) September 21, 2028."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner (\"GP\") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P. and HighCape Partners QP II, L.P. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Warrants for 2,058,623 shares of Common Stock were exercised by HighCape Partners QP II, L.P. and warrants for 42,954 shares of Common Stock were exercised by HighCape Partners II, L.P."}],"balance_after":0,"derivative":{"exercise_price":1.4275,"exercise_date":"2023-09-21","underlying":"Class A Common Stock","underlying_shares":2101577},"source":{"system":"sec-edgar","filing":"0001104659-24-084967","document":"tm2420609-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1957359/000110465924084967/tm2420609-2_4seq1.xml","form_type":"4"}},{"id":1444442,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":2,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":3,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":6,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":7,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42461,"kind":"organization","name":"HighCape Partners QP II, L.P.","position":8,"cik":"0001770972","reported_name":"HighCape Partners QP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42459,"kind":"organization","name":"HighCape Partners GP II, LLC","position":9,"cik":"0001957360","reported_name":"HighCape Partners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42460,"kind":"organization","name":"HighCape Partners GP II, L.P.","position":10,"cik":"0001957359","reported_name":"HighCape Partners GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-08-01T20:54:16.000Z","date":"2024-07-30","kind":"other","planned":false,"acquired":true,"shares":2101577,"price":1.4275,"value":3000001.1675,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P; (vi) 86,613 shares of Common Stock held of record by HighCape Partners II, L.P.; and (vii) 4,151,015 shares of Common Stock held of record by HighCape Partners QP II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner (\"GP\") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P. and HighCape Partners QP II, L.P. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."}],"balance_after":9100232,"source":{"system":"sec-edgar","filing":"0001104659-24-084967","document":"tm2420609-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1957359/000110465924084967/tm2420609-2_4seq1.xml","form_type":"4"}},{"id":1484416,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T21:00:15.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":31835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date."}],"balance_after":31835,"derivative":{"exercise_price":3.4,"expiration_date":"2034-06-05","underlying":"Class A Common Stock","underlying_shares":31835},"source":{"system":"sec-edgar","filing":"0001415889-24-016249","document":"form4-06102024_050612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708527/000141588924016249/form4-06102024_050612.xml","form_type":"4"}},{"id":1674974,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-01-20T00:05:54.000Z","date":"2024-01-18","kind":"sale","planned":true,"acquired":false,"shares":4242,"price":3.705,"value":15716.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2023."}],"balance_after":211445,"source":{"system":"sec-edgar","filing":"0001576885-24-000026","document":"wk-form4_1705709143.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688524000026/wk-form4_1705709143.xml","form_type":"4"}},{"id":1684453,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":2,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":3,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":6,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":7,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42461,"kind":"organization","name":"HighCape Partners QP II, L.P.","position":8,"cik":"0001770972","reported_name":"HighCape Partners QP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42459,"kind":"organization","name":"HighCape Partners GP II, LLC","position":9,"cik":"0001957360","reported_name":"HighCape Partners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42460,"kind":"organization","name":"HighCape Partners GP II, L.P.","position":10,"cik":"0001957359","reported_name":"HighCape Partners GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-01-08T21:09:54.000Z","date":"2023-12-28","kind":"other","planned":false,"acquired":false,"shares":2154116,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This Form 4 relates to the pro rata distribution by Elutia PIPE Investment LP of its shares of Class A Common Stock and Warrants to its partners, without payment of consideration by such partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,436,077 Units originally purchased by Elutia PIPE Investment LP for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock (the \"Common Stock\") and one warrant to purchase one and one-half shares of Common Stock. The shares of Common Stock and Warrants reported as transferred in this Form 4 are being distributed to Elutia PIPE Investment LP's partners without payment of consideration by them."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Includes (i) 2,058,623 shares of Common Stock issuable upon exercise of a warrant held by HighCape Partners QP II, L.P.; and (ii) 42,954 shares of Common Stock issuable upon exercise of a warrant held by HighCape Partners II, L.P."}],"balance_after":2101577,"derivative":{"exercise_price":1.4275,"exercise_date":"2023-09-21","underlying":"Class A Common Stock","underlying_shares":2154116},"source":{"system":"sec-edgar","filing":"0001104659-24-002239","document":"tm242311-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1957359/000110465924002239/tm242311-2_4seq1.xml","form_type":"4"}},{"id":1684452,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":2,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":3,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":6,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":7,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42461,"kind":"organization","name":"HighCape Partners QP II, L.P.","position":8,"cik":"0001770972","reported_name":"HighCape Partners QP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42459,"kind":"organization","name":"HighCape Partners GP II, LLC","position":9,"cik":"0001957360","reported_name":"HighCape Partners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42460,"kind":"organization","name":"HighCape Partners GP II, L.P.","position":10,"cik":"0001957359","reported_name":"HighCape Partners GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-01-08T21:09:54.000Z","date":"2023-12-28","kind":"other","planned":false,"acquired":false,"shares":1436077,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This Form 4 relates to the pro rata distribution by Elutia PIPE Investment LP of its shares of Class A Common Stock and Warrants to its partners, without payment of consideration by such partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,436,077 Units originally purchased by Elutia PIPE Investment LP for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock (the \"Common Stock\") and one warrant to purchase one and one-half shares of Common Stock. The shares of Common Stock and Warrants reported as transferred in this Form 4 are being distributed to Elutia PIPE Investment LP's partners without payment of consideration by them."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P; (vi) 43,659 shares of Common Stock held of record by HighCape Partners II, L.P.; and (vii) 2,092,392 shares of Common Stock held of record by HighCape Partners QP II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner (\"GP\") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment, LP. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment, LP. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."}],"balance_after":6998655,"source":{"system":"sec-edgar","filing":"0001104659-24-002239","document":"tm242311-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1957359/000110465924002239/tm242311-2_4seq1.xml","form_type":"4"}},{"id":1686988,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-04T21:20:23.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":159000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":159000,"derivative":{"exercise_price":4.23,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":159000},"source":{"system":"sec-edgar","filing":"0001576885-24-000010","document":"wk-form4_1704403210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688524000010/wk-form4_1704403210.xml","form_type":"4"}},{"id":1686987,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:20:23.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":106000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":215687,"source":{"system":"sec-edgar","filing":"0001576885-24-000010","document":"wk-form4_1704403210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000157688524000010/wk-form4_1704403210.xml","form_type":"4"}},{"id":1764465,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":2,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":3,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":6,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":7,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42461,"kind":"organization","name":"HighCape Partners QP II, L.P.","position":8,"cik":"0001770972","reported_name":"HighCape Partners QP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42459,"kind":"organization","name":"HighCape Partners GP II, LLC","position":9,"cik":"0001957360","reported_name":"HighCape Partners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42460,"kind":"organization","name":"HighCape Partners GP II, L.P.","position":10,"cik":"0001957359","reported_name":"HighCape Partners GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2023-10-05T20:43:44.000Z","date":"2021-09-21","kind":"purchase","planned":false,"acquired":true,"shares":4255693,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within the 2,837,128 Units purchased by the reporting persons for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock (the \"Common Stock\") and one warrant to purchase one and one-half shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Includes (i) 2,058,623 shares of Common Stock issuable upon exercise of a warrant held by HighCape Partners QP II, L.P.; (ii) 42,954 shares of Common Stock issuable upon exercise of a warrant held by HighCape Partners II, L.P; and (iii) 2,154,116 shares of Common Stock issuable upon exercise of a warrant held by Elutia PIPE Investment, LP."}],"balance_after":4255693,"derivative":{"exercise_price":1.4275,"exercise_date":"2023-09-21","underlying":"Class A Common Stock","underlying_shares":4255693},"source":{"system":"sec-edgar","filing":"0001826279-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1957359/000182627923000002/primary_doc.xml","form_type":"4"}},{"id":1764464,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":2,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":3,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":6,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":7,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42461,"kind":"organization","name":"HighCape Partners QP II, L.P.","position":8,"cik":"0001770972","reported_name":"HighCape Partners QP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42459,"kind":"organization","name":"HighCape Partners GP II, LLC","position":9,"cik":"0001957360","reported_name":"HighCape Partners GP II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42460,"kind":"organization","name":"HighCape Partners GP II, L.P.","position":10,"cik":"0001957359","reported_name":"HighCape Partners GP II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-10-05T20:43:44.000Z","date":"2021-09-21","kind":"purchase","planned":false,"acquired":true,"shares":2837128,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within the 2,837,128 Units purchased by the reporting persons for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock (the \"Common Stock\") and one warrant to purchase one and one-half shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P; (vi) 43,659 shares of Common Stock held of record by HighCape Partners II, L.P.; (vii) 2,092,392 shares of Common Stock held of record by HighCape Partners QP II, L.P.; and (viii) 1,436,077 shares of Common Stock held of record by Elutia PIPE Investment, LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner (\"GP\") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment, LP.  In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P.  In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment, LP. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."}],"balance_after":8434732,"source":{"system":"sec-edgar","filing":"0001826279-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1957359/000182627923000002/primary_doc.xml","form_type":"4"}},{"id":1858532,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T19:32:41.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's First Amended and Restated Non-Employee Director Compensation Policy and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors."}],"balance_after":25000,"derivative":{"exercise_price":2.37,"expiration_date":"2033-06-07","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-23-070300","document":"tm2318353-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465923070300/tm2318353-1_4seq1.xml","form_type":"4"}},{"id":1858531,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T19:32:41.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's First Amended and Restated Non-Employee Director Compensation Policy and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors."}],"balance_after":37500,"derivative":{"exercise_price":2.37,"expiration_date":"2033-06-07","underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001104659-23-070300","document":"tm2318353-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465923070300/tm2318353-1_4seq1.xml","form_type":"4"}},{"id":2052112,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-18T21:27:06.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":150800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":150800,"derivative":{"exercise_price":6.11,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":150800},"source":{"system":"sec-edgar","filing":"0001209191-23-003750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919123003750/doc4.xml","form_type":"4"}},{"id":2052111,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-01-18T21:27:06.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":109687,"source":{"system":"sec-edgar","filing":"0001209191-23-003750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919123003750/doc4.xml","form_type":"4"}},{"id":2072120,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-03T22:23:33.000Z","date":"2022-12-29","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vested and became exercisable on January 1, 2022; the remainder vested or shall vest and become exercisable in 36 equal monthly installments such that the option shall be fully vested on January 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":401369,"derivative":{"exercise_price":1.19,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-000327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919123000327/doc4.xml","form_type":"4"}},{"id":2072119,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-01-03T22:23:33.000Z","date":"2022-12-29","kind":"exercise","acquired":true,"shares":50000,"price":1.19,"value":59500.0,"ownership":{"direct":true},"balance_after":76187,"source":{"system":"sec-edgar","filing":"0001209191-23-000327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919123000327/doc4.xml","form_type":"4"}},{"id":2076016,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T23:09:06.000Z","date":"2022-12-22","kind":"grant","acquired":true,"shares":17533,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors."}],"balance_after":17533,"derivative":{"exercise_price":3.8,"expiration_date":"2032-12-21","underlying":"Class A Common Stock","underlying_shares":17533},"source":{"system":"sec-edgar","filing":"0001415889-22-013020","document":"form4-12272022_111257.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000141588922013020/form4-12272022_111257.xml","form_type":"4"}},{"id":2093163,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-12-07T21:31:59.000Z","date":"2022-12-05","kind":"purchase","acquired":true,"shares":735000,"price":4.75,"value":3491250.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Includes: (i) 53,818 shares of Class A Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Class A Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Class A Common Stock held of record by HighCape Capital, L.P.; (vi) 15,023 shares of Class A Common Stock held of record by HighCape Partners II, L.P.; and (vii) 719,977 shares of Class A Common Stock held of record by HighCape Partners QP II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner of HighCape Partners GP, L.P., which is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Messrs. Rakin and Zuga are the managing members of HighCape Capital, LLC, which is the general partner of HighCape Capital, L.P. Messrs. Rakin and Zuga are also the managing members of HighCape Partners GP II, LLC, which is the general partner of HighCape Partners GP II, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held of record by each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held of record by HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held of record by each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held of record by each such entity. Mr. Rakin may be deemed to beneficially own the securities held of record by the Kevin L. Rakin Irrevocable Trust. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."}],"balance_after":5597604,"source":{"system":"sec-edgar","filing":"0001104659-22-125197","document":"tm2232148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465922125197/tm2232148-1_4seq1.xml","form_type":"4"}},{"id":2237482,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T12:28:35.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":22090,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors."}],"balance_after":22090,"derivative":{"exercise_price":6.28,"expiration_date":"2032-06-06","underlying":"Class A Common Stock","underlying_shares":22090},"source":{"system":"sec-edgar","filing":"0001415889-22-006330","document":"form4-06092022_050626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000141588922006330/form4-06092022_050626.xml","form_type":"4"}},{"id":2237481,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T12:28:35.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":22090,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors."}],"balance_after":22090,"derivative":{"exercise_price":6.28,"expiration_date":"2032-06-06","underlying":"Class A Common Stock","underlying_shares":22090},"source":{"system":"sec-edgar","filing":"0001415889-22-006330","document":"form4-06092022_050626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000141588922006330/form4-06092022_050626.xml","form_type":"4"}},{"id":2428550,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-21T21:22:39.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on January 19, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":150000,"derivative":{"exercise_price":5.19,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-004427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919122004427/doc4.xml","form_type":"4"}},{"id":2476968,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-10T21:22:31.000Z","date":"2021-12-08","kind":"purchase","acquired":true,"shares":58962,"price":4.24,"value":249998.88,"ownership":{"direct":false,"nature":"Held by the Kevin L. Rakin Irrevocable Trust"},"balance_after":90807,"source":{"system":"sec-edgar","filing":"0001104659-21-148591","document":"tm2135128-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465921148591/tm2135128-1_4seq1.xml","form_type":"4"}},{"id":2476967,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-10T21:22:31.000Z","date":"2021-12-08","kind":"purchase","acquired":true,"shares":353773,"price":4.24,"value":1499997.52,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; and (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner of HighCape Partners GP, L.P., which is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."}],"balance_after":4862604,"source":{"system":"sec-edgar","filing":"0001104659-21-148591","document":"tm2135128-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465921148591/tm2135128-1_4seq1.xml","form_type":"4"}},{"id":2637815,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series B Preferred Stock","published_at":"2021-07-08T22:18:23.000Z","date":"2021-07-06","kind":"exercise","acquired":false,"shares":10528,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."}],"balance_after":10528,"derivative":{"underlying":"Common Stock","underlying_shares":10528},"source":{"system":"sec-edgar","filing":"0001209191-21-046031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919121046031/doc4.xml","form_type":"4"}},{"id":2637814,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series A-1 Preferred Stock","published_at":"2021-07-08T22:18:23.000Z","date":"2021-07-06","kind":"exercise","acquired":false,"shares":15659,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."}],"balance_after":15659,"derivative":{"underlying":"Common Stock","underlying_shares":15659},"source":{"system":"sec-edgar","filing":"0001209191-21-046031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919121046031/doc4.xml","form_type":"4"}},{"id":2637813,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-07-08T22:18:23.000Z","date":"2021-07-06","kind":"exercise","acquired":true,"shares":26187,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 6, 2021, each share of Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the \"Preferred\nStock\") converted into Common Stock on a one-for-one basis without payment of further consideration upon closing of the initial public offering of\nthe Issuer's common stock. The shares had no expiration date."}],"balance_after":26187,"source":{"system":"sec-edgar","filing":"0001209191-21-046031","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000120919121046031/doc4.xml","form_type":"4"}},{"id":2675342,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T21:44:30.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":14082,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors"}],"balance_after":14082,"derivative":{"exercise_price":10.41,"expiration_date":"2031-06-06","underlying":"Class A Common Stock","underlying_shares":14082},"source":{"system":"sec-edgar","filing":"0001415889-21-002895","document":"form4-06092021_020617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000141588921002895/form4-06092021_020617.xml","form_type":"4"}},{"id":2675341,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-09T21:44:30.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":14082,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors"}],"balance_after":14082,"derivative":{"exercise_price":10.41,"expiration_date":"2031-06-06","underlying":"Class A Common Stock","underlying_shares":14082},"source":{"system":"sec-edgar","filing":"0001415889-21-002895","document":"form4-06092021_020617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000141588921002895/form4-06092021_020617.xml","form_type":"4"}},{"id":3008033,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2020-10-14T01:57:57.000Z","date":"2020-10-13","kind":"other","acquired":false,"shares":7655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"HighCape Partners QP, L.P. is the record holder of these securities."}],"balance_after":0,"derivative":{"exercise_price":5.4424,"exercise_date":"2017-03-27","expiration_date":"2027-03-01","underlying":"Class A Common Stock","underlying_shares":7655},"source":{"system":"sec-edgar","filing":"0001104659-20-114637","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465920114637/a4.xml","form_type":"4"}},{"id":3008032,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-10-14T01:57:57.000Z","date":"2020-10-13","kind":"exercise","acquired":false,"shares":31133977,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering.  In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering.  In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each share of Series A preferred stock was automatically converted into 0.071659417 shares of Class A common stock upon the closing of the Issuer's initial public offering.  In addition, immediately prior to the consummation of the Issuer's underwritten initial public offering of its Class A common stock, each holder of Series A preferred stockholders received, for each share of Series A preferred stock then held, 0.820876470 shares of Class A common stock (the quotient of $13.9549 divided by $17.00, the price per share of Class A common stock in such offering)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of (i) 43,255 shares of Class A common stock held by HighCape Partners, L.P.; (ii) 3,211,838 shares of Class A common stock held by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A common stock held by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A common stock held by HighCape Co-Investment Vehicle II, LLC and (v) 48,931 shares of Class A common stock held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4062451},"source":{"system":"sec-edgar","filing":"0001104659-20-114637","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465920114637/a4.xml","form_type":"4"}},{"id":3008031,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-10-14T01:57:57.000Z","date":"2020-10-13","kind":"purchase","acquired":true,"shares":441176,"price":17,"value":7499992.0,"ownership":{"direct":false,"nature":"Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Consists of (i) 49,118 shares of Class A common stock held by HighCape Partners, L.P.; (ii) 3,652,355 shares of Class A common stock held by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A common stock held by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A common stock held by HighCape Co-Investment Vehicle II, LLC and (v) 48,931 shares of Class A common stock held by HighCape Capital, L.P."}],"balance_after":4508831,"source":{"system":"sec-edgar","filing":"0001104659-20-114637","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465920114637/a4.xml","form_type":"4"}},{"id":3008030,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-10-14T01:57:57.000Z","date":"2020-10-13","kind":"tax_withholding","acquired":false,"shares":2451,"price":5.4424,"value":13339.3224,"ownership":{"direct":false,"nature":"Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"HighCape Partners QP, L.P. is the record holder of these securities."}],"balance_after":4067655,"source":{"system":"sec-edgar","filing":"0001104659-20-114637","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465920114637/a4.xml","form_type":"4"}},{"id":3008029,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-10-14T01:57:57.000Z","date":"2020-10-13","kind":"other","acquired":true,"shares":7655,"price":5.4424,"value":41661.572,"ownership":{"direct":false,"nature":"Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"HighCape Partners QP, L.P. is the record holder of these securities."}],"balance_after":4070106,"source":{"system":"sec-edgar","filing":"0001104659-20-114637","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465920114637/a4.xml","form_type":"4"}},{"id":3008028,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":82013,"kind":"person","name":"HighCape Capital, L.P.","position":1,"cik":"0001826279","reported_name":"HighCape Capital, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71105,"kind":"organization","name":"HIGHCAPE PARTNERS, L.P.","position":2,"cik":"0001598046","reported_name":"HIGHCAPE PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71106,"kind":"organization","name":"HIGHCAPE PARTNERS QP, L.P.","position":3,"cik":"0001598026","reported_name":"HIGHCAPE PARTNERS QP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71103,"kind":"organization","name":"HighCape Partners GP, LLC","position":4,"cik":"0001819933","reported_name":"HighCape Partners GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71104,"kind":"organization","name":"HighCape Partners GP, L.P.","position":5,"cik":"0001819932","reported_name":"HighCape Partners GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71107,"kind":"organization","name":"HighCape Co-Investment Vehicle I, LLC","position":6,"cik":"0001819988","reported_name":"HighCape Co-Investment Vehicle I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":71108,"kind":"organization","name":"HighCape Co-Investment Vehicle II, LLC","position":7,"cik":"0001820044","reported_name":"HighCape Co-Investment Vehicle II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82033,"kind":"organization","name":"HighCape Capital, LLC","position":8,"cik":"0001827500","reported_name":"HighCape Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":68870,"kind":"person","name":"Zuga Matt","position":9,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38103,"kind":"person","name":"RAKIN KEVIN","position":10,"cik":"0001184421","reported_name":"RAKIN KEVIN","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2020-10-14T01:57:57.000Z","date":"2020-10-13","kind":"exercise","acquired":true,"shares":4062451,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Consists of (i) 43,255 shares of Class A common stock held by HighCape Partners, L.P.; (ii) 3,211,838 shares of Class A common stock held by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A common stock held by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A common stock held by HighCape Co-Investment Vehicle II, LLC and (v) 48,931 shares of Class A common stock held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which in turn is the general partner of HighCape Partners GP, L.P., which in turn is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which in turn is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any."}],"balance_after":4062451,"source":{"system":"sec-edgar","filing":"0001104659-20-114637","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1184421/000110465920114637/a4.xml","form_type":"4"}},{"id":3372523,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":1665,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":1665,"derivative":{"exercise_price":28.65,"exercise_date":"2019-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":67},"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372522,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":1665,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":1665},"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372521,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":123653,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":123653,"derivative":{"exercise_price":28.65,"exercise_date":"2017-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":5008},"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372520,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":123653,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":123653},"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372519,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":72417,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2931},"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372518,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":5377928,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":217816},"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372517,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":6643,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":269},"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372516,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":493357,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19982},"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372515,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":217816,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":498606,"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372514,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":19982,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":280790,"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372513,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":2931,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":15875,"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372512,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":269,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":12944,"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372511,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-08","kind":"purchase","acquired":true,"shares":75901,"price":13,"value":986713.0,"ownership":{"direct":false,"nature":"By HighCape Partners QP, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 183,907 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":260808,"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}},{"id":3372510,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":68870,"kind":"person","name":"Zuga Matt","position":1,"cik":"0001790214","reported_name":"Zuga Matt","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:57:28.000Z","date":"2019-11-08","kind":"purchase","acquired":true,"shares":10220,"price":13,"value":132860.0,"ownership":{"direct":false,"nature":"By HighCape Partners, L.P."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 2,455 shares of common stock received by the reporting person as a payment-in-kind dividend on Series A Preferred Stock and Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":12675,"source":{"system":"sec-edgar","filing":"0001192482-19-000428","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000428/edgar.xml","form_type":"4"}}]}